Choate Investment Advisors »

Crispr Therapeutics shares owned by Choate Investment Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Choate Investment Advisors from 13F filings

Historical chart of Choate Investment Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Choate Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Choate Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $214k 3.3k 64.81
2024-03-31 $249k 3.7k 68.16
2021-06-30 $276k 1.7k 161.97

More positions owned by Choate Investment Advisors

Ishares Tr Core S&p500 Etf (IVV)
Harris Oakmark Etf Trust Oakmark U S Lrg (OAKM)
Ishares Tr Intrm Gov Cr Etf (GVI)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr Series Trust Spdr S&p 500 Etf (SPYX)
Ishares Tr National Mun Etf (MUB)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Home Depot (HD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Choate Investment Advisors

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Sumitomo Mitsui Trust Holdings
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics